ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $791,918 | -6.9% | 29,179 | +5.5% | 0.00% | 0.0% |
| Q2 2023 | $850,422 | -36.5% | 27,665 | -25.5% | 0.00% | 0.0% |
| Q1 2023 | $1,338,515 | -4.9% | 37,150 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $1,407,781 | -13.8% | 35,622 | -12.4% | 0.00% | 0.0% |
| Q3 2022 | $1,633,000 | -16.3% | 40,649 | -12.5% | 0.00% | 0.0% |
| Q2 2022 | $1,952,000 | +24.5% | 46,432 | +15.3% | 0.00% | 0.0% |
| Q1 2022 | $1,568,000 | +3.3% | 40,257 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $1,518,000 | +39.0% | 38,089 | +26.1% | 0.00% | 0.0% |
| Q3 2021 | $1,092,000 | -16.0% | 30,216 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $1,300,000 | +7.0% | 31,723 | +13.9% | 0.00% | 0.0% |
| Q1 2021 | $1,215,000 | +78.7% | 27,847 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $680,000 | -7.0% | 13,591 | -21.8% | 0.00% | 0.0% |
| Q3 2020 | $731,000 | +36.9% | 17,375 | +58.0% | 0.00% | – |
| Q2 2020 | $534,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |